Close Menu

marketing agreement

NEW YORK (GenomeWeb News) – IncellDx today said it has reached a deal to offer its molecular diagnostic test for human papillomavirus in India.

NEW YORK (GenomeWeb News) – CombiMatrix said today that Pathology has chosen it to serve as the exclusive provider of Pathology's chromosomal microarray tests for the products of conception testing market in the US.

NEW YORK (GenomeWeb News) – CML HealthCare and XDx jointly announced today that CML has licensed exclusive rights to market XDx's AlloMap test initially in Ontario, Canada but with an option to extend the rights across the country.

NEW YORK (GenomeWeb News) – While GenMark Diagnostics continues to seek clarification around the consequences of Luminex's collaboration and licensing deal wit

NEW YORK (GenomeWeb News) – Exiqon and Asuragen announced today the signing of a service center agreement allowing Asuragen to offer real-time PCR services based on Exiqon's miRcury LNA Universal RT-microRNA PCR products.

NEW YORK (GenomeWeb News) – Applied Spectral Imaging and BioDot today announced an agreement to sell and market a genetic analysis solution combining technologies from both firms.

NEW YORK (GenomeWeb News) – Foundation Medicine and Memorial Sloan-Kettering Cancer Center today said they are partnering to co-develop a molecular diagnostic tool to match patients who have hematologic cancers with the most appropriate targeted therapies or clinical trials.

NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

NEW YORK (GenomeWeb News) – Predictive Biosciences will offer its molecular diagnostic bladder cancer tests to Arup Laboratories' national network of clients under a deal announced today.

NEW YORK (GenomeWeb News) – Eastern Biotech and Life Sciences, Dubai and BGI Health have partnered to make available to parts of the Middle East a non-invasive prenatal diagnostic test for detecting trisomy 21.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.